Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
AASB, abundant, adherence, adjunct, advertising, andin, andtheircash, Antioxidative, ASENT, attain, Balentine, biotech, Bourke, busy, cardiovascular, channel, chemotherapy, clozapine, consortia, DATATOP, Dentistry, Deprenyl, detain, Diane, disubstituted, downstream, dutetetrabenazine, editor, enhance, entacapone, facilityin, FBR, flat, Fluence, fuel, glial, half, Huntingtondisease, hydrogen, impossible, incomplete, incorrect, inhibitory, inInternal, injunctive, inNeurobiology, inThe, JAMA, JonesTrading, journalAging, journalNeuron, knowingly, labile, Lasagna, lazabemide, Limitedand, neurogenetic, Newark, newin, NOL, nonclinical, nonclinicalin, Noxopharm, NY, ofour, ofsubstantia, ofThe, outpatient, panel, pathogenic, PCAOB, penalty, performedin, played, pramipexole, Presentationare, properly, PSP, radiation, raw, reactive, rebate, recall, recordkeeping, redistribute, resignation, resigned, resubmit, Rochester, rotigitine, scalable, scarce, seize, selegiline, Senate, stable, statementspresent, store, strict, strictly, suspend, TCJA, termianted, Terragenic, thande, theCompany, theconsolidatedfinancial, theJournal, theseconsolidatedfinancial, thesubstantia, thought, Tocopherol, unavailable, untitled, warning, waste, water, withInternational
Removed:
academically, accelerated, angular, appraisal, assimilating, Azilect, background, Biomolecular, bringing, CERSI, cessation, chair, chorea, clear, climate, clinically, College, compliant, continuity, Corticobasal, Craig, delirium, Deloitte, dementia, destroy, differential, encapsulation, evolving, exploiting, facilitate, formally, Framework, France, generic, genotoxicity, glycogen, Great, HD, Hyderabad, immunotherapy, Imperial, improving, inducing, ingredient, inhibiting, initiated, IRWIN, kinase, Lewy, London, manufacturer, maturation, metallocomplex, methylphenidate, mix, modulate, nitrosative, Northwest, noted, oncosil, Parade, Parkville, Patheon, payout, pharmacologic, pivotal, PK, preclinical, preservation, Prof, psychiatric, Psychiatry, Reddy, retired, Richard, Ritchie, rod, rotating, route, Royal, schizophrenia, social, statistically, stipulated, sustained, Sweden, synthase, synucleinopathy, telemetry, titled, toxicokinetic, transition, tyrosine, undergoing, voluntary, wire, Xenazine
Filing tables
Filing exhibits
ATHE similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-220886) and FormS-8 (No. 333-153669) of Prana Biotechnology Limited of our report dated August 31, 2018 relating to the financial statements, which appears in this Form 20-F.
/s/ PricewaterhouseCoopers | |
PricewaterhouseCoopers | |
Melbourne, Australia | |
August 31, 2018 |